• No results found

University of Groningen Metabolic and mitogenic functions of fibroblast growth factor 1 Struik, Dicky

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Metabolic and mitogenic functions of fibroblast growth factor 1 Struik, Dicky"

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Metabolic and mitogenic functions of fibroblast growth factor 1 Struik, Dicky

DOI:

10.33612/diss.133879075

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Struik, D. (2020). Metabolic and mitogenic functions of fibroblast growth factor 1. University of Groningen. https://doi.org/10.33612/diss.133879075

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

1

fibroblast growth factor 1

(3)

2

The research described in this thesis was carried out at the Laboratory of Pediatrics (Head: prof. dr. F. Kuipers), Section Molecular Metabolism and Nutrition, University Medical Center Groningen, The Netherlands. The research was funded by grants from the Dutch Diabetes Foundation (grant 2012.00.1537 to J.W.J.), The Netherlands Organization for Scientific Research (VIDI grant 016.126.338 to J.W.J. and VICI grant 016.176.640 to J.W.J.), the De Cock Stichting, and European Foundation for the Study of Diabetes (award supported by EFSD/Novo Nordisk). The printing of this thesis was financially supported by the University of Groningen, the University Medical Center Groningen, and the Groningen University Institute for Drug Exploration.

Cover design: by Dicky Struik created with BioRender.com (front: human FGF1 at 1.10Å) ISBN (print): 978-94-034-2879-6

ISBN (online): 978-94-034-2880-2

Printing: Ridderprint BV, www.ridderprint.nl

Copyright © Dicky Struik. All rights reserved. No part of this book may be reproduced or transmitted in any form or by any means without the permission of the author and the copyright holders of the published articles.

(4)

3

Metabolic and mitogenic functions

of fibroblast growth factor 1

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. C. Wijmenga en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op

woensdag 14 oktober om 12:45 uur

door

Dirk Struik

geboren op 15 mei 1984

(5)

4

Promotores

Prof. dr. J.W. Jonker Prof. dr. H.J. Verkade

Copromotor

dr. J.K. Kruit

Beoordelingscommissie

Prof. dr. A.J.A. van de Sluis Prof. dr. M.A.T.M. van Vugt Prof. dr. E. Kalkhoven

(6)

5 Roos E. Eilers

Qui, sul bordo di quel che sappiamo, a contatto con l'oceano di quanto non sappiamo, brillano il mistero del mondo, la bellezza del mondo, e ci lasciano senza fiato – Carlo Rovelli, Sette Brevi Lezioni di Fisica (Here, on the edge of what we know, in contact with the ocean of the unknown, shines the mystery and beauty of the world. And it’s breathtaking – Carlo Rovelli,

(7)

6

Contents

Chapter 1: Introduction ... 7

Chapter 2: Fibroblast Growth Factors in control of lipid metabolism: from biological function to clinical application ... 39

Chapter 3: Pegbelfermin (BMS-986036): an investigational PEGylated Fibroblast Growth Factor 21 Analogue for the treatment of Non-Alcoholic Steatohepatitis (NASH) ... 57

Chapter 4: Effective treatment of steatosis and steatohepatitis by fibroblast growth factor 1 in mouse models of non-alcoholic fatty liver disease ... 75

Chapter 5: Discovery-based proteomics identifies ApoB as a target of recombinant fibroblast growth factor 1 ... 99

Chapter 6: Fibroblast growth factor 1 normalizes glucose metabolism in ob/ob mice by enhancing beta-adrenergic activity ... 117

Chapter 7: FGF1 stimulates acute and chronic glucose uptake via MEK1/2-dependent regulation of GLUT1 and GLUT4 in 3T3-L1 adipocytes ... 139

Chapter 8: A single mutation in the heparin-binding site of fibroblast growth factor 1 leads to uncoupling of DNA synthesis and mitosis ... 157

Chapter 9: Validation of peptide-based tyrosine kinase and phosphatase activity micro-arrays to study fibroblast growth factor 1 signaling ... 175

Chapter 10: Profiling of the fibroblast growth factor system in post-mortem hypothalamus tissue of lean and obese humans ... 193

Chapter 11: Discussion ... 211 Summary ... 235 Samenvatting ... 239 Dankwoord ... 245 Curriculum vitae ... 251 Publications ... 253

Referenties

GERELATEERDE DOCUMENTEN

The research described in this thesis was conducted at the Department of Pediatrics, Section Molecular Genetics, and the Department of Genetics, University Medical Centre

The work described in this thesis is performed at the Department of Pediatrics, Center for Liver, Digestive, and Metabolic Diseases, University of Groningen, University Medical

Reduced levels of FGF19 are generally observed in obesity and related disorders, including T2D, gestational diabetes, non- alcoholic fatty liver disease (NAFLD) and (NASH)

Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double- blind, placebo-controlled,

In addition to its potent anti-steatotic action, rFGF1 also suppressed hepatic inflammation in ob/ob mice as indicated by reduced mRNA expression of a range of hepatic

Een verhoogde sympathische activiteit lijkt ook een rol te spelen bij de metabole effecten van FGF19, FGF21 en na toediening van FGF1 in het brein.. Gezamenlijk geven

In humans, FGF-based drugs primarily improve lipid- and bile acid metabolism, while glucose metabolism remains mostly unaffected (Degirolamo et al. and this thesis). and this

The work in this thesis was carried out at the Department of Pediatrics, Center for Liver, Digestive, and Metabolic Diseases, University Medical Center